Nirogy Therapeutics Presented at Keystone Symposia on Cancer Immunotherapy: Decoding the Cancer Immunity Interactome. British Columbia, CANADA

Framingham, MA, March 30, 2022, Nirogy Therapeutics, a biopharmaceutical company focused on oncology and Immune diseases, presented at the Cancer Immunotherapy: Decoding the cancer immunity interactome, Keystone Conference that took place from March 21-25, 2022.

A poster highlighting pre-clinical data of a small molecule dual inhibitor of lactate transporters demonstrates the potential of immune activation in the TME by differential metabolic reprogramming of various immune cells in the TME on treatment with the compound.

nirogy therapeutics to- present at keystone symposia on cancer immunotherapy decoding the cancer immunity interactome british columbia canada
The conference poster presentation “A dual MCT1 and MCT4 inhibitor blocking lactate transport impacts human immune cell response under conditions mimicking the tumor microenvironment” is available on our website at https://nirogytx.com/press-releases-and-company-news/.

About Nirogy

Nirogy Therapeutics is a biotechnology company based in Boston, MA, developing novel small molecules to target cellular transporters. The company is currently advancing a class of small molecules intended to disrupt metabolic and immune mechanisms operative in the tumor microenvironment. Follow-on platform programs are targeting additional disease pathways in oncology as well as autoimmune diseases.

For more information, please visit www.nirogytx.com or follow us on Twitter and LinkedIn.

More Posts

Share:

Send Us A Message

Scroll to Top

This website uses cookies to ensure you get the best experience on our website.

Vincent P. Sandanayaka, Ph.D.

FOUNDER

At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt mollitia animi, id est laborum et dolorum fuga. Et harum quidem rerum facilis est et expedita distinctio. Nam libero tempore, cum soluta nobis est eligendi optio cumque nihil impedit quo minus id quod maxime placeat facere possimus, omnis voluptas assumenda est, omnis dolor repellendus. Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet ut et voluptates repudiandae sint et molestiae non recusandae. Itaque earum rerum hic tenetur a sapiente delectus, ut aut reiciendis voluptatibus maiores alias consequatur aut perferendis doloribus asperiores repellat